Literature DB >> 21352981

Defining patient-prosthesis mismatch and its effect on survival in patients with impaired ejection fraction.

David A Cotoni1, Robert T Palac, Lawrence J Dacey, Daniel J O'Rourke.   

Abstract

BACKGROUND: How best to define patient-prosthesis mismatch (PPM) continues to be debated. Over time, the indexed effective orifice area has become the most widely used method. However, the clinical relevance of PPM remains controversial.
METHODS: The indexed geometric orifice area and indexed effective orifice area were calculated for 143 patients having undergone aortic valve replacement with a normal left ventricular function 0.45 or less. Using the indexed geometric orifice area method, PPM was defined as nonsignificant if 1.2 cm(2)/m(2) or greater and as significant if less than 1.2 cm(2)/m(2). Using the indexed effective orifice area method, PPM was considered as nonsignificant if greater than 0.85 cm(2)/m(2), as moderate if greater than 0.65 cm(2)/m(2) and less than or equal to 0.85 cm(2)/m(2), and as severe PPM if 0.65 cm(2)/m(2) or less.
RESULTS: The number of patients classified as having PPM differed according to the method used to predict its presence (PPM: Effective orifice area method = 72.7%; geometric method = 19.6%). Regardless of the method used to classify PPM there was no significant effect on mortality (adjusted hazard ratio: 2.65 at 1 year, 0.99 at 5 years, 0.92 at 9 years; p = not significant). The postoperative mean transvalvular gradient (17.1 ± 6.5 mm Hg) and left ventricular function (0.50 ± 0.145) improved significantly compared with the preoperative findings.
CONCLUSIONS: The method used to calculate PPM resulted in significant classification discordance. However, regardless of classification, the presence of PPM did not adversely affect long-term outcome.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21352981     DOI: 10.1016/j.athoracsur.2010.11.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience.

Authors:  Angelo M Dell'Aquila; Dominik Schlarb; Stefan R B Schneider; Jürgen R Sindermann; Andreas Hoffmeier; Gerrit Kaleschke; Sven Martens; Andreas Rukosujew
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-15

2.  Early outcomes and hemodynamics after implantation of the Trifecta aortic bioprosthesis.

Authors:  Hiroyuki Seo; Yasushi Tsutsumi; Osamu Monta; Satoshi Numata; Sachiko Yamazaki; Shohei Yoshida; Takaaki Samura; Hirokazu Ohashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-17

3.  Patient prosthesis mismatch after aortic valve replacement: An Indian perspective.

Authors:  Shreedhar S Joshi; T Ashwini; Antony George; A M Jagadeesh
Journal:  Ann Card Anaesth       Date:  2016 Jan-Mar

4.  The effect of patient-prosthesis mismatch on survival after aortic and mitral valve replacement: a 10 year, single institution experience.

Authors:  Sudeep Das De; Ashok Nanjappa; Karim Morcos; Sadia Aftab; John Butler; Vivek Pathi; Philip Curry; Sukumaran Nair
Journal:  J Cardiothorac Surg       Date:  2019-12-06       Impact factor: 1.637

5.  Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement.

Authors:  Bart M Koene; Mohamed A Soliman Hamad; Wobbe Bouma; Massimo A Mariani; Kathinka C Peels; Jan-Melle van Dantzig; Albert H van Straten
Journal:  J Cardiothorac Surg       Date:  2013-04-17       Impact factor: 1.637

6.  Patient-prosthesis mismatch in patients with aortic valve replacement.

Authors:  Yuichiro Kaminishi; Yoshio Misawa; Junjiro Kobayashi; Hiroaki Konishi; Hiroaki Miyata; Noboru Motomura; Shin-ichi Takamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-13

7.  Can postoperative mean transprosthetic pressure gradient predict survival after aortic valve replacement?

Authors:  Bart M Koene; Mohamed A Soliman Hamad; Wobbe Bouma; Massimo A Mariani; Kathinka C Peels; Jan-Melle van Dantzig; Albert H van Straten
Journal:  Clin Res Cardiol       Date:  2013-10-18       Impact factor: 5.460

8.  Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study.

Authors:  Gopichand Mannam; Yugal Mishra; Rajan Modi; Alla Gopala Krishna Gokhale; Rajan Sethuratnam; Kaushal Pandey; Rajneesh Malhotra; Sumit Anand; Anushreeta Borah; Sushan Mukhopadhyay; Dhiren Shah; Tek Singh Mahant
Journal:  J Cardiothorac Surg       Date:  2018-09-25       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.